Skip to content

Clinical trials

Aortic Valve Stenosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aortic Valve Stenosis Country / region: Netherlands Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20103
20112
20125
20134
201412
20154
201610
20175
20184
20199
202011
20218
20225
20238
20246
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting17
Active, not recruiting16
Unknown status13
Terminated5
Not yet recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center10
Edwards Lifesciences8
Medtronic Cardiac Rhythm and Heart Failure7
St. Antonius Hospital7
Abbott Medical Devices6
Institut für Pharmakologie und Präventive Medizin6
Medtronic Cardiovascular5
Boston Scientific Corporation4
Corcym S.r.l4
Radboud University Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aortic Valve Stenosis105
Heart Valve Diseases16
Cardiovascular Diseases14
Aortic Valve Disease13
Heart Diseases9
Aortic Valve Insufficiency7
Coronary Artery Disease5
Hemorrhage5
Heart Failure4
Embolism and Thrombosis3

Trials

Showing 26 to 50 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.